Case report: Milk oral immunotherapy for adult-onset cow's milk-induced anaphylaxis.

IF 2.8 Q3 ALLERGY
Asia Pacific Allergy Pub Date : 2025-12-01 Epub Date: 2025-12-02 DOI:10.5415/apallergy.0000000000000218
Jae-Hyuk Jang, Sooyoung Lee, Young-Min Ye
{"title":"Case report: Milk oral immunotherapy for adult-onset cow's milk-induced anaphylaxis.","authors":"Jae-Hyuk Jang, Sooyoung Lee, Young-Min Ye","doi":"10.5415/apallergy.0000000000000218","DOIUrl":null,"url":null,"abstract":"<p><p>While food allergies affect individuals across all age groups, oral immunotherapy (OIT) has been widely studied and implemented in pediatric populations. Here, we report a successful case of cow's milk (CM) OIT in a 60-year-old male with adult-onset cow milk allergy. The patient who was previously tolerated with CM initially presented with generalized pruritus, rash, dyspnea, urticaria, and dizziness occurring 4 hours after consuming milk-containing foods. The patient was positive on the skin prick test and for specific IgEs to milk (24.4 kU/L) and casein (31.2 kU/L). After diagnosis, CM OIT was initiated using bread containing milk protein. The protocol began with a 1/4 slice of milk bread (1.55 g of milk protein) and gradually increased to 1 full slice (6.2 g of milk protein) over the course of 4 years. Throughout the period, the patient's immunological markers consistently improved, with his CM-specific IgE level decreasing from 24.40 to 1.50 kU/L and his casein-specific IgE level decreasing from 31.20 to 2.24 kU/L. The patient successfully completed an oral food challenge with 190 mL of cow milk and currently maintains a daily consumption of 200 mL of CM without adverse reactions. This case demonstrates that CM OIT can be successfully implemented in elderly patients with adult-onset CM allergy. The clinical and immunological responses suggest that immune modulation remains possible even in older adults, suggesting potential therapeutic options for adult-onset food allergies.</p>","PeriodicalId":8488,"journal":{"name":"Asia Pacific Allergy","volume":"15 4","pages":"343-345"},"PeriodicalIF":2.8000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12672181/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia Pacific Allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5415/apallergy.0000000000000218","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

Abstract

While food allergies affect individuals across all age groups, oral immunotherapy (OIT) has been widely studied and implemented in pediatric populations. Here, we report a successful case of cow's milk (CM) OIT in a 60-year-old male with adult-onset cow milk allergy. The patient who was previously tolerated with CM initially presented with generalized pruritus, rash, dyspnea, urticaria, and dizziness occurring 4 hours after consuming milk-containing foods. The patient was positive on the skin prick test and for specific IgEs to milk (24.4 kU/L) and casein (31.2 kU/L). After diagnosis, CM OIT was initiated using bread containing milk protein. The protocol began with a 1/4 slice of milk bread (1.55 g of milk protein) and gradually increased to 1 full slice (6.2 g of milk protein) over the course of 4 years. Throughout the period, the patient's immunological markers consistently improved, with his CM-specific IgE level decreasing from 24.40 to 1.50 kU/L and his casein-specific IgE level decreasing from 31.20 to 2.24 kU/L. The patient successfully completed an oral food challenge with 190 mL of cow milk and currently maintains a daily consumption of 200 mL of CM without adverse reactions. This case demonstrates that CM OIT can be successfully implemented in elderly patients with adult-onset CM allergy. The clinical and immunological responses suggest that immune modulation remains possible even in older adults, suggesting potential therapeutic options for adult-onset food allergies.

Abstract Image

病例报告:牛奶口服免疫疗法治疗成人发病的牛奶致过敏反应。
虽然食物过敏影响所有年龄组的个体,但口服免疫疗法(OIT)已在儿科人群中得到广泛研究和实施。在这里,我们报告一个成功的案例,牛奶(CM) OIT在一个60岁的男性成人发病的牛奶过敏。先前耐受CM的患者在食用含牛奶食物4小时后出现全身瘙痒、皮疹、呼吸困难、荨麻疹和头晕。皮肤点刺试验阳性,乳特异性IgEs阳性(24.4 kU/L),酪蛋白阳性(31.2 kU/L)。诊断后,CM OIT开始使用含有牛奶蛋白的面包。该方案从1/4片牛奶面包(含1.55克牛奶蛋白)开始,在4年的时间里逐渐增加到1片整片(含6.2克牛奶蛋白)。在此期间,患者的免疫指标持续改善,cm特异性IgE水平从24.40降至1.50 kU/L,酪蛋白特异性IgE水平从31.20降至2.24 kU/L。患者成功地完成了190毫升牛奶的口服食物挑战,目前每天保持200毫升CM的摄入量,无不良反应。本病例证明CM OIT可以成功地应用于成人发病的老年CM过敏患者。临床和免疫学反应表明,即使在老年人中,免疫调节仍然是可能的,这为成人发病的食物过敏提供了潜在的治疗选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.50
自引率
5.90%
发文量
33
期刊介绍: Asia Pacific Allergy (AP Allergy) is the official journal of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). Although the primary aim of the journal is to promote communication between Asia Pacific scientists who are interested in allergy, asthma, and clinical immunology including immunodeficiency, the journal is intended to be available worldwide. To enable scientists and clinicians from emerging societies appreciate the scope and intent of the journal, early issues will contain more educational review material. For better communication and understanding, it will include rational concepts related to the diagnosis and management of asthma and other immunological conditions. Over time, the journal will increase the number of original research papers to become the foremost citation journal for allergy and clinical immunology information of the Asia Pacific in the future.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书